跳至主要内容
临床试验/CTRI/2020/08/027408
CTRI/2020/08/027408尚未招募未知

Prospective study comparing the efficacy of Eplerenone versus Placebo in first episode of central serous chorioretinopathy

AFMRC Office of DGAFMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Acute CSCR (defined as duration of less than 6 months)
  • 2.Age group between 20-50 years

排除标准

  • 1.Renal diseases
  • 2.History of dyselectrolytemia
  • 3.Hypertension
  • 4.Patient expressing inability to follow up for minimum 32 weeks

研究者

发起方
AFMRC Office of DGAFMS

相似试验

尚未招募
不适用
A prospective study to compare the efficacy of empirical Vs tailored therapy in refractory GERD
CTRI/2023/02/049407not applicable
尚未招募
Unknown
Comparison on the efficacy of Epleys Maneuver and its combination with Ayurvedic management which includes Kalyanaka grita Nasya,internal administration of Drakshadi kashaya and Eladi vati in the condition Benign Paroxysmal Positional Vertigo(BPPV).
CTRI/2023/12/060810Dr Praveena Nair
已完成
不适用
An exploratory study to evaluate the efficacy of enteral nutrition using thickening agents on physical properties in stomach and blood glucose fluctuatioHealthy adult
JPRN-UMIN000035110Mejiro Second General Hospital6
进行中(未招募)
1 期
Comparison of the safety and efficacy of eplivanserin and lormetazepam in the treatment of insomnia characterized by sleep maintenance difficulties. A 4 week, randomized, double-blind, comparative, parallel-group study.----------------------------------------------------------------------------------Comparación de la seguridad y eficacia de eplivanserina y lormetazepam en el tratamiento del insomnio caracterizado por la dificultad para mantener el sueño. Estudio comparativo, aleatorizado, doble ciego, con grupos paralelos de 4 semanas de duración.
EUCTR2007-003822-28-ESsanofi-aventis recherche et développement382
进行中(未招募)
不适用
Comparison of the safety and efficacy of eplivanserin and lormetazepam in the treatment of insomnia characterized by sleep maintenance difficulties. A 4 week, randomized, double-blind, comparative, parallel-group study. - DREAMSChronic primary insomnia and sleep maintenance difficulties.
EUCTR2007-003822-28-NLsanofi-aventis recherche et développement382